144 related articles for article (PubMed ID: 10204584)
21. Effects of prestorage vs poststorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to platelets.
Wang RR; Triulzi DJ; Qu L
Am J Clin Pathol; 2012 Aug; 138(2):255-9. PubMed ID: 22904138
[TBL] [Abstract][Full Text] [Related]
22. An animal model of allogeneic donor platelet refractoriness: the effect of the time of leukodepletion.
Blajchman MA; Bardossy L; Carmen RA; Goldman M; Heddle NM; Singal DP
Blood; 1992 Mar; 79(5):1371-5. PubMed ID: 1536960
[TBL] [Abstract][Full Text] [Related]
23. The utility of < or =3-day-old whole-blood platelets in reducing the incidence of febrile nonhemolytic transfusion reactions.
Kelley DL; Mangini J; Lopez-Plaza I; Triulzi DJ
Transfusion; 2000 Apr; 40(4):439-42. PubMed ID: 10773056
[TBL] [Abstract][Full Text] [Related]
24. Determination
Thuku NW; Shikuku K; Mbugua A
Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of pooled platelet concentrates using prestorage versus poststorage WBC reduction: impact of filtration timing.
Ferrer F; Rivera J; Corral J; Gonzalez-Conejero R; Lozano ML; Vicente V
Transfusion; 2000 Jul; 40(7):781-8. PubMed ID: 10924604
[TBL] [Abstract][Full Text] [Related]
26. Factors influencing moderate to severe reactions to PLT transfusions: experience of the TRAP multicenter clinical trial.
Enright H; Davis K; Gernsheimer T; McCullough JJ; Woodson R; Slichter SJ
Transfusion; 2003 Nov; 43(11):1545-52. PubMed ID: 14617313
[TBL] [Abstract][Full Text] [Related]
27. Experimental animal model of refractoriness to donor platelets: the effect of plasma removal and the extent of white cell reduction on allogeneic alloimmunization.
Bordin JO; Bardossy L; Blajchman MA
Transfusion; 1993 Oct; 33(10):798-801. PubMed ID: 8236419
[TBL] [Abstract][Full Text] [Related]
28. Febrile reactions after platelet transfusion: the effect of single versus multiple donors.
Chambers LA; Kruskall MS; Pacini DG; Donovan LM
Transfusion; 1990; 30(3):219-21. PubMed ID: 1967118
[TBL] [Abstract][Full Text] [Related]
29. Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness.
Seftel MD; Growe GH; Petraszko T; Benny WB; Le A; Lee CY; Spinelli JJ; Sutherland HJ; Tsang P; Hogge DE
Blood; 2004 Jan; 103(1):333-9. PubMed ID: 12958065
[TBL] [Abstract][Full Text] [Related]
30. Blood utilisation and transfusion reactions in adult patients transfused with conventional or pathogen-reduced platelets.
Bahar B; Schulz WL; Gokhale A; Spencer BR; Gehrie EA; Snyder EL
Br J Haematol; 2020 Feb; 188(3):465-472. PubMed ID: 31566724
[TBL] [Abstract][Full Text] [Related]
31. Effect of premedication guidelines and leukoreduction on the rate of febrile nonhaemolytic platelet transfusion reactions.
Patterson BJ; Freedman J; Blanchette V; Sher G; Pinkerton P; Hannach B; Meharchand J; Lau W; Boyce N; Pinchefsky E; Tasev T; Pinchefsky J; Poon S; Shulman L; MacK P; Thomas K; Blanchette N; Greenspan D; Panzarella T
Transfus Med; 2000 Sep; 10(3):199-206. PubMed ID: 10972914
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
[TBL] [Abstract][Full Text] [Related]
33. White cell reduction in platelet concentrates and packed red cells by filtration: a multicenter clinical trial. The Trap Study Group.
Kao KJ; Mickel M; Braine HG; Davis K; Enright H; Gernsheimer T; Gillespie MJ; Kickler TS; Lee EJ; McCullough JJ
Transfusion; 1995 Jan; 35(1):13-9. PubMed ID: 7998062
[TBL] [Abstract][Full Text] [Related]
34. The relationship between the duration of platelet storage and the development of transfusion reactions.
Sarkodee-Adoo CB; Kendall JM; Sridhara R; Lee EJ; Schiffer CA
Transfusion; 1998 Mar; 38(3):229-35. PubMed ID: 9563401
[TBL] [Abstract][Full Text] [Related]
35. Pathophysiology of febrile nonhemolytic transfusion reactions.
Heddle NM
Curr Opin Hematol; 1999 Nov; 6(6):420-6. PubMed ID: 10546797
[TBL] [Abstract][Full Text] [Related]
36. Management of patients with hematologic malignancies and aplastic anemia who are refractory to platelet transfusions.
Sandler SG
Haematologia (Budap); 1998; 29(1):1-11. PubMed ID: 9704252
[TBL] [Abstract][Full Text] [Related]
37. Clinical evaluation of transfusion of prestorage-leukoreduced apheresis platelets.
Ogawa Y; Wakana M; Tanaka K; Oka K; Aso H; Hayashi M; Seno T; Ishida T; Nomura S; Fukuhara S
Vox Sang; 1998; 75(2):103-9. PubMed ID: 9784662
[TBL] [Abstract][Full Text] [Related]
38. A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions.
Heddle NM; Klama LN; Griffith L; Roberts R; Shukla G; Kelton JG
Transfusion; 1993 Oct; 33(10):794-7. PubMed ID: 8236418
[TBL] [Abstract][Full Text] [Related]
39. WBC-reduced platelet concentrates from pooled buffy coats in additive solution: an evaluation of in vitro and in vivo measures.
van der Meer PF; Pietersz RN; Tiekstra MJ; Huijgens PC; Dekker WJ; Reesink HW
Transfusion; 2001 Jul; 41(7):917-22. PubMed ID: 11452160
[TBL] [Abstract][Full Text] [Related]
40. A prospective observational study of the effect of platelet transfusions on levels of platelet-derived cytokines, chemokines and interleukins in acute leukaemia patients with severe chemotherapy-induced cytopenia.
Apelseth TO; Hervig T; Wentzel-Larsen T; Petersen K; Reikvam H; Bruserud Ø
Eur Cytokine Netw; 2011 Mar; 22(1):52-62. PubMed ID: 21388914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
